Get the Weekly Intelligence Brief — top committee picks every Sunday.

CCK vs DDS

Crown Holdings vs Dillard's, Inc. — AI-powered side-by-side comparison
CCK
Crown Holdings
70
Buy
VS
DDS
Dillard's, Inc.
56
Watch
MetricCCKDDS
AI Score 70 56
Price $119.98 $648.33
P/E Ratio 17.19× 15.36×
ROE 24.5% 32.1%
Revenue Growth YoY
Gross Margin 17.5% 37.8%
Debt / Equity 2.19× 0.27×
Dividend Yield 1.1% 4.8%
RSI (14) 58.0 80.2
Beta 0.578 1.187
Expected Upside +8.3%

AI Committee View

Current Innellis committee reasoning for CCK versus DDS.
CCK leads by 14 points.

CCK scores 70/100 (Buy) versus DDS at 56/100 (Watch).

CCK Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
  • Weekly RSI at 77 -- overbought on the larger timeframe too — Technical
DDS Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -7.0% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • P/E of 14.9 is inexpensive for the broad market — Value
  • ROE of 33.8% shows genuine earnings power backing the valuation — Value
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • Price-to-book of 5.6x prices in significant intangible value — Value
  • Revenue declining -7.0% YoY -- this is not a growth story right now — Growth
  • EPS declining -6.7% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CCK Full Analysis DDS Full Analysis